引用本文:赖祥丽,郭红云(综述),冯国生(审校).非小细胞肺癌放射增敏的研究进展[J].中国临床新医学,2017,10(3):290-293.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1765次   下载 1200 本文二维码信息
码上扫一扫!
分享到: 微信 更多
非小细胞肺癌放射增敏的研究进展
赖祥丽,郭红云(综述),冯国生(审校)
545005 柳州,广西医科大学第四附属医院内科(赖祥丽);530021 南宁,广西壮族自治区人民医院化疗一区(郭红云,冯国生)
摘要:
[摘要] 肺癌是目前对人类威胁最大的肿瘤之一,在所有的肺癌患者中,非小细胞肺癌(non-small cell lung cancer,NSCLC)占75%~80%,70%的患者在确诊时已错过了根治性手术的机会,只能采取放化疗、靶向治疗的手段,但效果却不尽人意。因此,如何提高NSCLC的放疗敏感性是亟待解决的问题。该文就NSCLC放射增敏的研究进展作一综述。
关键词:  非小细胞肺癌  放射增敏  增敏剂
DOI:10.3969/j.issn.1674-3806.2017.03.31
分类号:R 734.2
基金项目:
The research progress of radiosensitization in non-small cell lung cancer
LAI Xiang-li, GUO Hong-yun, FENG Guo-sheng
Department of Internal Medicine, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou 545005, China
Abstract:
[Abstract] Currently, lung cancers are the biggest threat to human health in all cancers, in which non-small cell lung cancer(NSCLC) accounts for about 75%~80% and 70% of the patients with NSCLC have missed the chance to receive the radical surgery when diagnosed. Radiation,chemotherapy and targeted therapy are the main therapies, but the prognosis is still poor. Therefore, improving the radiation sensitivity of NSCLC still needs to be solved. In this article,we review the research progress of radiotherapy sensitization in NSCLC.
Key words:  Non-small cell lung cancer(NSCLC)  Radiosensitization  Sensitizer